The onset of side effects of a common cancer treatment, anti-PD-1 therapy can be identified up to 3 years after treatment...
The post Anti-PD-1 therapy linked to delayed onset of skin disease appeared first on European Pharmaceutical Review.
Original Article: Anti-PD-1 therapy linked to delayed onset of skin disease